In simple terms, EyePoint Pharmaceuticals, Inc. has 35.309 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.806% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -2.297%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -3.404%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust -0.724% return, is a testament to EyePoint Pharmaceuticals, Inc.'s adeptness in optimizing resource deployment. EyePoint Pharmaceuticals, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -1.380%. Furthermore, the proficiency of EyePoint Pharmaceuticals, Inc. in capital utilization is underscored by a remarkable -0.803% return on capital employed.
Stock Prices
EyePoint Pharmaceuticals, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6.67, while its low point bottomed out at $5.98. This variance in figures offers investors a lucid insight into the roller-coaster ride that is EyePoint Pharmaceuticals, Inc.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
